Skip to main
LIXT

Lixte Biotech (LIXT) Market Capitalization Overview

Market Cap: $30.02M as of Jan 8, 2026

$30.02M
$2.80M (10.28%)past month
As of Jan 8, 2026, Lixte Biotech (LIXT) has a market capitalization of $30.02M. Over the past 30 days, its market cap has increased by 31.4%, while in the last 12 months, it has decreased by -4.58%.

Market capitalization represents the total value of Lixte Biotech as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Lixte Biotech (LIXT) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Lixte Biotech (LIXT) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Lixte Biotech (LIXT) Market Cap History

DateMarket CapChange
Dec 1, 2025$23.39M+15.74%
Nov 3, 2025$20.21M-7.90%
Oct 1, 2025$21.95M+16.18%
Sep 2, 2025$18.89M+33.95%
Aug 1, 2025$14.10M+345.11%
Jul 1, 2025$3.17M-16.31%
Jun 2, 2025$3.79M+11.90%
May 1, 2025$3.39M+5.44%
Apr 1, 2025$3.21M-1.24%
Mar 3, 2025$3.25M-47.30%
Feb 3, 2025$6.17M+23.42%
Jan 2, 2025$4.99M+3.25%

Lixte Biotech (LIXT) End of Year Market Cap History

DateMarket CapChange
2026$30.02M-4.58%
2025$31.46M+588.92%
2024$4.57M-13.63%
2023$5.29M-37.62%
2022$8.48M-48.20%
2021$16.36M

FAQs About Lixte Biotech (LIXT) Market Cap

As of Jan 8, 2026, the market capitalization of Lixte Biotech (LIXT) is $30.02M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Lixte Biotech’s market capitalization has increased by 10.28%, changing from $27.22M to $30.02M as of Jan 8, 2026.

In the last 3 months, Lixte Biotech’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Lixte Biotech’s market capitalization increased from $4.57M in January to $31.46M in December, reflecting a 588.92% change.

In the past five years, Lixte Biotech (LIXT) has had a compound annual growth rate (CAGR) of 13.97% in market capitalization. This means its market cap has grown at an average rate of 13.97% per year.

Lixte Biotech (LIXT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.